EUVIMEDEUVIMED entdecken
Crossref

Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia

Katsushige Kawase, Ayumi Taguchi, Aya Ishizaka, Jason Lin, Toshihide Ueno, Daisuke Yoshimoto, Satoko Eguchi, Seiichiro Mori, Kenbun Sone, Mayuyo Mori, Syuji Yonekura, Toyoyuki Hanazawa und 6 weitere

HLA · 2024

DOI: 10.1111/tan.15509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Katsushige Kawase und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Loss of Heterozygosity, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The Japan Society for the Promotion of Science (JSPS), Japan Agency for Medical Research and Development, Chiba Prefecture Budget.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss of heterozygosity (LOH) has been reported to occur in HLA regions in cervical intraepithelial neoplasia (CIN) and cervical cancer. However, the details of how this is related to the progression of CIN have been unclear. In this study, we examined the human papillomavirus (HPV) antigen‐presenting capacity of people with CIN and the significance of LOH of HLA class I in the progression of CIN. It was shown that differences in antigen‐presenting capacity among each case depended on HLA types, not HPV genotypes. Focusing on the HLA type, there was a positive correlation between antigen‐presenting capacity against HPV and the frequency of allelic loss. Furthermore, the lost HLA‐B alleles had a higher HPV antigen‐presenting capacity than intact alleles. In addition, frequency of LOH of HLA class I was significantly higher in advanced CIN (CIN2–3) than in cervicitis or early‐stage CIN (CIN1): around half of CIN2–3 had LOH of any HLA class I. Moreover, the antigen‐presenting capacity against E5, which is the HPV proteins that facilitate viral escape from this immune surveillance by suppressing HLA class I expression, had the most significant impact on the LOH in HLA‐B. This study suggests that HPV evades immune surveillance mechanisms when host cells lose the capacity for antigen presentation by HLA class I molecules, resulting in long‐term infection and progression to advanced lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical DysplasiaUterine Cervical NeoplasmsLoss of HeterozygosityHistocompatibility Antigens Class IPapillomavirus InfectionsHumansFemaleAntigen PresentationAdultAllelesPapillomaviridaeImmunologic SurveillanceMiddle AgedGenotype

Stichwörter der Autor:innen

HLA class Icervical cancercervical intraepithelial neoplasmhuman papillomavirusloss of heterozygosity

Substanzen

Histocompatibility Antigens Class I

Autor:innen und Institutionen

  • Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Department of Otorhinolaryngology/Head & Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
  • Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

ORCID-Profile: Kei Kawana, Masahito Kawazu

Förderung

  • The Japan Society for the Promotion of Science (JSPS)
  • Japan Agency for Medical Research and Development
  • Chiba Prefecture Budget
  • The Seiichi Imai Memorial Foundation
  • Taiju Life Social Welfare Foundation
  • Takeda Science Foundation
  • Princess Takamatsu Cancer Research Fund
  • Uehara Memorial Foundation

Zitieren

APA

Kawase, K., Taguchi, A., Ishizaka, A., Lin, J., Ueno, T., Yoshimoto, D., Eguchi, S., Mori, S., Sone, K., Mori, M., Yonekura, S., Hanazawa, T., Maeda, D., Kukimoto, I., Mano, H., Osuga, Y., Kawana, K., & Kawazu, M. (2024). Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia. HLA. https://doi.org/10.1111/tan.15509

Vancouver

Kawase K, Taguchi A, Ishizaka A, Lin J, Ueno T, Yoshimoto D, et al. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia. HLA. 2024. doi:10.1111/tan.15509

BibTeX
@article{Kawase2024,
  author = {Kawase, Katsushige and Taguchi, Ayumi and Ishizaka, Aya and Lin, Jason and Ueno, Toshihide and Yoshimoto, Daisuke and Eguchi, Satoko and Mori, Seiichiro and Sone, Kenbun and Mori, Mayuyo and Yonekura, Syuji and Hanazawa, Toyoyuki and Maeda, Daichi and Kukimoto, Iwao and Mano, Hiroyuki and Osuga, Yutaka and Kawana, Kei and Kawazu, Masahito},
  title = {Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia},
  journal = {HLA},
  year = {2024},
  doi = {10.1111/tan.15509}
}
Kostenlos starten →